Welcome to LookChem.com Sign In|Join Free
  • or
5-methyl-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1382948-40-4

Post Buying Request

1382948-40-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1382948-40-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1382948-40-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,2,9,4 and 8 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1382948-40:
(9*1)+(8*3)+(7*8)+(6*2)+(5*9)+(4*4)+(3*8)+(2*4)+(1*0)=194
194 % 10 = 4
So 1382948-40-4 is a valid CAS Registry Number.

1382948-40-4Relevant academic research and scientific papers

Ultrasound-assisted 3-component reaction in acetic acid alone: Catalyst/promoter/ligand free synthesis of bioactive pyrazolo[1,5-a]pyrimidines

Suresha, Namburi,Durgaraoa, Bodapati Veera,Ratnakar,Kolli, Sunder Kumar,Ashfaq, Mohd Ashraf,Rao, Mandava V. Basaveswara,Pal, Manojit

, p. 1176 - 1183 (2017/11/14)

Background: Acetic acid alone when employed as a solvent under ultrasound irradiation has been found to be effective for the three-component reaction involving ethyl-5- A mino-1H-pyrazole-4-carboxylate, aromatic aldehydes and terminal alkynes in the prese

Discovery, structure - Activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase

Patnaik, Samarjit,Zheng, Wei,Choi, Jae H.,Motabar, Omid,Southall, Noel,Westbroek, Wendy,Lea, Wendy A.,Velayati, Arash,Goldin, Ehud,Sidransky, Ellen,Leister, William,Marugan, Juan J.

, p. 5734 - 5748 (2012/08/07)

A major challenge in the field of Gaucher disease has been the development of new therapeutic strategies including molecular chaperones. All previously described chaperones of glucocerebrosidase are enzyme inhibitors, which complicates their clinical development because their chaperone activity must be balanced against the functional inhibition of the enzyme. Using a novel high throughput screening methodology, we identified a chemical series that does not inhibit the enzyme but can still facilitate its translocation to the lysosome as measured by immunostaining of glucocerebrosidase in patient fibroblasts. These compounds provide the basis for the development of a novel approach toward small molecule treatment for patients with Gaucher disease. This article not subject to U.S. Copyright. Published 2012 by the American Chemical Society.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1382948-40-4